The Joint Corp. (JYNT): Price and Financial Metrics


The Joint Corp. (JYNT): $16.37

-0.09 (-0.55%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

JYNT POWR Grades


  • Quality is the dimension where JYNT ranks best; there it ranks ahead of 93.97% of US stocks.
  • The strongest trend for JYNT is in Value, which has been heading up over the past 179 days.
  • JYNT's current lowest rank is in the Sentiment metric (where it is better than 13.11% of US stocks).

JYNT Stock Summary

  • JYNT's current price/earnings ratio is 81.19, which is higher than 91.27% of US stocks with positive earnings.
  • Of note is the ratio of JOINT Corp's sales and general administrative expense to its total operating expenses; 85.47% of US stocks have a lower such ratio.
  • The volatility of JOINT Corp's share price is greater than that of 85.9% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to JOINT Corp, a group of peers worth examining would be EIG, TIXT, GFF, CASY, and SWK.
  • JYNT's SEC filings can be seen here. And to visit JOINT Corp's official web site, go to www.thejoint.com.

JYNT Valuation Summary

  • In comparison to the median Healthcare stock, JYNT's price/sales ratio is 450% higher, now standing at 20.9.
  • Over the past 83 months, JYNT's price/earnings ratio has gone up 360.5.
  • Over the past 83 months, JYNT's price/sales ratio has gone up 11.4.

Below are key valuation metrics over time for JYNT.

Stock Date P/S P/B P/E EV/EBIT
JYNT 2021-08-31 20.9 54.6 85.2 175.0
JYNT 2021-08-30 20.9 54.5 85.1 174.8
JYNT 2021-08-27 20.2 52.7 82.3 169.1
JYNT 2021-08-26 19.2 50.0 78.1 160.5
JYNT 2021-08-25 19.1 49.9 78.0 160.3
JYNT 2021-08-24 19.1 49.7 77.6 159.4

JYNT Growth Metrics

    Its 4 year price growth rate is now at 326.33%.
  • Its 5 year net income to common stockholders growth rate is now at 130.58%.
  • Its 2 year net cashflow from operations growth rate is now at 518.4%.
Over the past 34 months, JYNT's revenue has gone up $45,488,944.

The table below shows JYNT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 80.85965 15.23278 6.57577
2021-09-30 75.79653 16.72738 17.56817
2021-06-30 70.21546 17.16138 17.23503
2021-03-31 62.58646 11.98287 14.66665
2020-12-31 58.68298 11.18324 13.16731
2020-09-30 55.52 9.724186 3.826316

JYNT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • JYNT has a Quality Grade of A, ranking ahead of 95.69% of graded US stocks.
  • JYNT's asset turnover comes in at 1.069 -- ranking 12th of 443 Trading stocks.
  • ADC, REFR, and MAA are the stocks whose asset turnover ratios are most correlated with JYNT.

The table below shows JYNT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.069 0.894 0.218
2021-03-31 1.068 0.892 0.189
2020-12-31 1.098 0.889 0.164
2020-09-30 1.158 0.888 0.130
2020-06-30 1.164 0.888 0.097
2020-03-31 1.222 0.886 0.115

JYNT Price Target

For more insight on analysts targets of JYNT, see our JYNT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $124.60 Average Broker Recommendation 1.58 (Moderate Buy)

JYNT Stock Price Chart Interactive Chart >

Price chart for JYNT

JYNT Price/Volume Stats

Current price $16.37 52-week high $111.06
Prev. close $16.46 52-week low $14.09
Day low $15.73 Volume 192,800
Day high $17.29 Avg. volume 316,874
50-day MA $30.12 Dividend yield N/A
200-day MA $64.50 Market Cap 236.73M

The Joint Corp. (JYNT) Company Bio


The Joint Corp. develops, owns, operates, franchises, supports, and manages chiropractic clinics in the United States. The company was founded in 2010 and is based in Scottsdale, Arizona.


JYNT Latest News Stream


Event/Time News Detail
Loading, please wait...

JYNT Latest Social Stream


Loading social stream, please wait...

View Full JYNT Social Stream

Latest JYNT News From Around the Web

Below are the latest news stories about JOINT Corp that investors may wish to consider to help them evaluate JYNT as an investment opportunity.

Joint Corp (JYNT) CEO Peter Holt on Q4 2021 Results - Earnings Call Transcript

Joint Corp (JYNT) Q4 2021 Earnings Conference Call February 24, 2022, 17:00 ET Company Participants Kirsten Chapman - Lippert/Heilshorn & Associates Peter Holt - CEO, President & Director Jake Singleton - CFO Conference Call Participants Linda Bolton-Weiser - D.A. Davidson & Co. Jeremy Hamblin - Craig-Hallum George Kelly - ROTH...

SA Transcripts on Seeking Alpha | February 25, 2022

The Joint Corp. 2021 Q4 - Results - Earnings Call Presentation

No summary available.

Seeking Alpha | February 25, 2022

Aerie, Schrodinger top healthcare gainers; while Baudax Bio, The Joint lead losers'' pack

Aerie Pharmaceuticals (AERI) +25%. Schrodinger (SDGR) +17%. Baudax Bio BXRX -55%. The Joint (JYNT) -15%.

Seeking Alpha | February 25, 2022

UPDATE -- The Joint Corp. Reports Preliminary Fourth Quarter and Year-end 2021 Financial Results

- Grows 2021 Revenue 38%, System-wide Sales 39%, and System-wide Comp Sales 29%, Compared to 2020 - - Sold 156 Franchise Licenses, Compared to 121 in 2020 - - Opened 130 Clinics, Including 20 Greenfields, Bringing the Total Corporate Count to 96 at Year End -

GlobeNewswire | February 24, 2022

The Joint Corp. (JYNT) Q4 Earnings Lag Estimates

The Joint Corp. (JYNT) delivered earnings and revenue surprises of -87.50% and 1.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 24, 2022

Read More 'JYNT' Stories Here

JYNT Price Returns

1-mo -51.16%
3-mo -66.38%
6-mo -82.53%
1-year -70.67%
3-year -6.24%
5-year 299.27%
YTD -75.08%
2021 150.15%
2020 62.70%
2019 93.99%
2018 67.74%
2017 87.17%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9592 seconds.